Neurofilament light chain as a diagnostic and prognostic biomarker in Guillain–Barré syndrome
Our results confirm sNfL as prognostic biomarker for GBS and the precision was improved using the age-adjusted sNfL Z score. NfL index and Qalb are potential diagnostic biomarkers for GBS.
Authors
- Jan Lycke (ORCID: https://orcid.org/0000-0002-7891-8466)
- Helen Farman
- Igal Rosenstein (ORCID: https://orcid.org/0000-0002-5078-9690)
- Clas Malmeström (ORCID: https://orcid.org/0000-0003-2477-0088)
- Markus Axelsson (ORCID: https://orcid.org/0000-0003-2036-4007)
- Oluf Andersen (ORCID: https://orcid.org/0000-0002-9089-0451)
- Brynhildur Hafsteinsdóttir (ORCID: https://orcid.org/0000-0001-7889-8453)
- Lenka Novakova (ORCID: https://orcid.org/0000-0001-7899-6395)
- Hans Rosén
- Nina Lagerström
- Bengt Nellgård (ORCID: https://orcid.org/0000-0003-2765-826X)
- Henrik Zetterberg (ORCID: https://orcid.org/0000-0002-4671-6763)
Institutions
- University of Wisconsin–Madison (US)
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- UK Dementia Research Institute (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
- University of Gothenburg (SE)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1007/s00415-024-12679-5
- Citations
- 13
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.80
Funders
- Rune och Ulla Amlövs Stiftelse för Neurologisk och Reumatologisk Forskning
- Swedish Foundation for MS Research
- Göteborgs Läkaresällskap
- Stiftelsen Edit Jakobssons Donationsfond
- Göteborgs Universitet